Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 13 studies | 22% ± 5% | |
memory B cell | 10 studies | 21% ± 4% | |
naive B cell | 10 studies | 18% ± 3% | |
plasma cell | 7 studies | 33% ± 10% | |
plasmacytoid dendritic cell | 7 studies | 21% ± 4% | |
GABAergic neuron | 3 studies | 24% ± 7% |
Insufficient scRNA-seq data for expression of PNOC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 78% | 105.74 | 2059 / 2642 | 52% | 4.26 | 369 / 705 |
ovary | 25% | 13.31 | 45 / 180 | 95% | 75.37 | 409 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.84 | 29 / 29 |
spleen | 100% | 451.67 | 241 / 241 | 0% | 0 | 0 / 0 |
stomach | 69% | 35.73 | 247 / 359 | 31% | 0.81 | 88 / 286 |
peripheral blood | 91% | 346.28 | 850 / 929 | 0% | 0 | 0 / 0 |
lung | 32% | 10.58 | 186 / 578 | 52% | 2.22 | 601 / 1155 |
intestine | 57% | 66.03 | 553 / 966 | 23% | 0.64 | 119 / 527 |
tonsil | 0% | 0 | 0 / 0 | 56% | 2.03 | 25 / 45 |
pancreas | 0% | 0.10 | 1 / 328 | 47% | 1.61 | 84 / 178 |
kidney | 26% | 15.25 | 23 / 89 | 16% | 0.65 | 147 / 901 |
bladder | 19% | 5.33 | 4 / 21 | 23% | 1.11 | 115 / 504 |
breast | 17% | 5.93 | 76 / 459 | 22% | 0.60 | 251 / 1118 |
thymus | 15% | 14.62 | 96 / 653 | 20% | 1.00 | 122 / 605 |
esophagus | 17% | 5.02 | 242 / 1445 | 17% | 0.39 | 32 / 183 |
uterus | 5% | 1.90 | 9 / 170 | 29% | 3.14 | 131 / 459 |
skin | 0% | 0.14 | 9 / 1809 | 31% | 1.16 | 145 / 472 |
prostate | 10% | 3.92 | 25 / 245 | 3% | 0.09 | 17 / 502 |
adrenal gland | 8% | 2.19 | 20 / 258 | 2% | 0.04 | 5 / 230 |
liver | 3% | 0.60 | 6 / 226 | 5% | 0.16 | 20 / 406 |
adipose | 5% | 1.73 | 55 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.10 | 3 / 80 |
blood vessel | 4% | 7.60 | 50 / 1335 | 0% | 0 | 0 / 0 |
heart | 1% | 0.26 | 11 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019233 | Biological process | sensory perception of pain |
GO_0007165 | Biological process | signal transduction |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0007600 | Biological process | sensory perception |
GO_0007270 | Biological process | neuron-neuron synaptic transmission |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0007565 | Biological process | female pregnancy |
GO_0097060 | Cellular component | synaptic membrane |
GO_0043679 | Cellular component | axon terminus |
GO_0005576 | Cellular component | extracellular region |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005886 | Cellular component | plasma membrane |
GO_0030425 | Cellular component | dendrite |
GO_0031628 | Molecular function | opioid receptor binding |
GO_0001515 | Molecular function | opioid peptide activity |
GO_0005184 | Molecular function | neuropeptide hormone activity |
Gene name | PNOC |
Protein name | Prepronociceptin [Cleaved into: Nocistatin; Nociceptin (Orphanin FQ) (PPNOC); Orphanin FQ2] Prepronociceptin |
Synonyms | OFQ |
Description | FUNCTION: [Nociceptin]: Ligand of the opioid receptor-like receptor OPRL1. It may act as a transmitter in the brain by modulating nociceptive and locomotor behavior. May be involved in neuronal differentiation and development. .; FUNCTION: [Nocistatin]: Blocks nociceptin action in pain transmission by inhibiting nociceptin-induced hyperalgesia and allodynia. .; FUNCTION: [Orphanin FQ2]: Has potent analgesic activity. . |
Accessions | ENST00000301908.8 [Q13519-1] ENST00000522209.1 [Q13519-2] ENST00000518479.5 E7EVP0 Q9BYY3 Q13519 |